Background The value of corticosteroids in severe acute asthma continues to be debated. Methods Ninety consecutive patients admitted to the emergency room with severe acute asthma were studied in a randomised, double blind, controlled trial to determine the efficacy of corticosteroids. Eighty two patients completed the study. All received oxygen therapy and intensive bronchodilator treatment. The patients were divided into three groups for steroid treatment, receiving intravenous methylprednisolone 10
Background The value of corticosteroids in severe acute asthma continues to be debated. Methods Ninety consecutive patients admitted to the emergency room with severe acute asthma were studied in a randomised, double blind, controlled trial to determine the efficacy of corticosteroids. Eighty two patients completed the study. All received oxygen therapy and intensive bronchodilator treatment. The patients were divided into three groups for steroid treatment, receiving intravenous methylprednisolone 10 mg/kg every four hours for 48 hours (29 patients, group A); intravenous methylprednisolone 2 mg/kg every 4 hours for 48 hours (27 patients, group B); or no intravenous corticosteroids (26 patients, group C). Results There were no differences on admission among the three groups in forced expiratory volume in one second (FEVy), forced vital capacity (FVC), peak expiratory flow (PEF), or arterial oxygen or carbon dioxide tension; and the rates of recovery in FEV,, FVC Previous treatment with xanthines (n) 15 17 20 Mean ( 5 4) 28-4 (6-63) 27-04 FEV,-forced expiratory volume in one second; FVC-forced vital capacity; PEF-peak expiratory flow; Pao2-arterial oxygen tension; Paco2-arterial carbon dioxide tension.
Conversion to SI units: 1 mm Hg t 0 133 kPa.
The protocol was approved by the hospital scientific committee and informed consent was obtained from each patient before entry to the study. Respiratory rate, heart rate, blood pressure, chest radiograph, electrocardiogram, arterial blood gases during the breathing of room air, and a complete blood count Were recorded when they entered. Spirometric measurements of forced expiratory volume in one second (FEV,) forced vital capacity (FVC), and peak expiratory flow (PEF) were also recorded.
The patients were all treated in the emergency room. Spirometry was repeated every hour for the first six hours, and arterial blood gases were measured at the end of the sixth hour. All tests were then repeated at 24 Results Patients' data on entry to the study are shown in the table. The three groups were similar in all the variables measured. In particular, there were no significant differences in mean FEVI, FVC, PEF, Pao2, Paco2, heart rate, or respiratory rate among the three groups when the subjects entered the study.
In all three treatment groups there was a gradual increase in FEV,, FVC, and PEF during the 48 hours of the study (fig 1) , but there were no significant differences between the rates of increase for the three groups. No significant differences were observed during the study in the changes in Pao2 and Paco2.
There was a significant increase in FEV, with time (p < 0-005), which was not affected by treatment group. There was also a significant 46-3% increase in PEF with time (p < 0-01), but the increase in FVC by 48 hours was not significantly greater than before treatment (fig 1) .
Among patients whose PEF had improved less than 15% above baseline after three hours (nine in group A, 11 in group B, and 12 in group C) there was a trend towards a faster recovery after three hours in patients from group A (fig  2A) , but this did not reach statistical significance.
In patients receiving regular treatment with oral corticosteroids before admission (11 patients in group A, five in group B, and seven in group C) an increase in PEF was observed after the third hour of treatment in patients of group A, but this was not significantly different from the subgroups in groups B and C ( fig 2B) .
No effect on any of the respiratory indices was related to the presence or absence of blood eosinophilia at the time of entry to the study. Six patients complained of epigastric discomfort: two in group A, three in group B, and one in group C. One patient in group B developed melaena from an active duodenal ulcer confirmed by endoscopy. One patient in group B developed transient sinus tachycardia immediately after the first intravenous bolus of methylprednisolone, but this did not occur after subsequent injections.
Discussion
Until a few years ago intravenous hydrocortisone was empirically considered essential for the treatment of severe acute asthma'6 17; but this view has been questioned in recent papers, which have stated that corticosteroids are of little or no value, even when administered in high doses. 5 Fanta et al,6 however, found significant differences in the response to treatment over 24 hours in patients with severe acute asthma between those who were given intravenous hydrocortisone and those who were not. The study included only patients who had not responded to treatment with bronchodilators during the previous eight hours. Other recent studies in adults'2 and in children'8 also appear to confirm the beneficial effect of steroids in severe acute asthma.
In a study of however, reach statistical significance, probably because of the wide scatter of PEF values. As pulmonary function in general is at its worst during the first few hours of severe acute asthma and when the risk of death is highest, '9 it is important to achieve a rapid improvement. 20 For that reason, given that corticosteroids do not begin to take effect in acute asthma until at least three hours after administration,21-25 and that it is impossible to know beforehand which patients will not respond to bronchodilators, it would seem advisable to administer intravenous corticosteroids to all patients with severe acute asthma as soon as possible. The question of how to identify those likely to benefit from corticosteroids remains open.
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